MAPT and Alzheimer disease: Some authors reported that brain organoids that use iPSCs derived from AD patients recapitulate AD-like characteristics, such as amyloid aggregation, hyperphosphorylated tau protein, and endosome abnormalities, and they are highly amenable to experimental manipulation.